PetMed Express reports preliminary Q4 sales $51.1M-$53.1M vs $66.5M last year

For the fiscal fourth quarter ended March 31, 2025, net sales are estimated to range from $51.1 million to $53.1 million compared to $66.5 million in the prior year period. Net loss is estimated to range from $9.9 million to $10.4 million compared to a net loss of $5.0 million in the prior year period. Net loss includes the tax expense impact of recording a valuation allowance on the Company’s net deferred tax assets of $6.4 million.